Stay updated on PD-L1 Selected HNSCC Clinical Trial
Sign up to get notified when there's something new on the PD-L1 Selected HNSCC Clinical Trial page.
![Latest website image capture](/pages/_next/image?url=https%3A%2F%2Fs3.us-west-2.amazonaws.com%2Fvp-files-ore%2Fresources%2F12months%2FUIHc9_CEylNjCYUj2F4MsIwoS4E.uncropped.jpg&w=3840&q=75)
Latest updates to the PD-L1 Selected HNSCC Clinical Trial page
- Check4 days agoChange DetectedThe website has been updated from version 2.10.2 to 2.10.3, indicating a new release.SummaryDifference0.3%
- Check11 days agoChange DetectedNew content was added on August 23, 2024, while previous content was removed on July 16, 2024.SummaryDifference0.6%
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.SummaryDifference0.3%
- Check32 days agoNo Change Detected
- Check46 days agoChange DetectedThe website has added new functionality for viewing and comparing study record versions in the latest update (v2.10.0), replacing the previous version (v2.9.7).SummaryDifference5%
- Check53 days agoChange DetectedA study on Pembrolizumab with or without Lenvatinib in a PD-L1 selected population for head and neck cancer showed results posted on 2024-07-16, replacing a previous study with results submitted on 2024-01-05.SummaryDifference2%
- Check54 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.3%
Stay in the know with updates to PD-L1 Selected HNSCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PD-L1 Selected HNSCC Clinical Trial page.